PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.75
Bid: 9.50
Ask: 10.00
Change: 0.10 (1.04%)
Spread: 0.50 (5.263%)
Open: 9.75
High: 9.75
Low: 9.75
Prev. Close: 9.65
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Strategic Alliance

11 Feb 2015 07:00

RNS Number : 5724E
Tekcapital plc
11 February 2015
 

11 February 2015

 

Tekcapital Plc

 

("Tekcapital", "the Company" or "the Group")

 

Tekcapital Announces a Strategic Alliance with Health Connexions™

 

 

Tekcapital plc (AIM: TEK), an international provider of technology and intellectual property services, is pleased to announce it has entered into a strategic alliance with Health Connexions™, to market InventionEvaluator more widely to pharmaceutical, medical device, diagnostic and healthcare companies.

 

InventionEvaluator, a division of Tekcapital, provides in-depth analytical reports that assess the commercial potential of new technologies and intellectual property, thereby enabling clients to make more informed decisions regarding investments in new technologies. As part of the Alliance, Health Connexionswill make the InventionEvaluator's reports available to its clients and network members worldwide.

 

Through the acquisition of InventionEvaluator (www.inventionevaluator.com), announced on the 23rd of July, 2014, Tekcapital has added an important additional service for clients, who are able to use this product to further determine and extract value from intellectual property.

 

Health Connexions™ is a Boston-based professional services firm with a global reach that provides Strategic Consulting, Market Research, Communications, Education & Training, and Care & Cost Management to healthcare, pharmaceutical, diagnostic and medical device companies (www.healthconnexions.com).

 

Commenting on the announcement, Dr. Clifford M. Gross, Executive Chairman of Tekcapital plc said:

 

"The acquisition of InventionEvaluator has expanded our service offering and client base. To further expand its market penetration into life science and health care companies, we are very excited to have entered into a strategic alliance with Health Connexions™. We believe their large network of leading companies focused on improving medical outcomes is an excellent fit with InventionEvaluator's reports, which provide guidance on the marketability of newly developed technologies."

Commenting on the announcement, Dawn Van Dam, President & CEO of Health Connexions™ said:

 

"We are very enthusiastic to be able to provide the InventionEvaluator service to our clients worldwide. Health Connexions™ has developed an extensive network and unique collaborative model in consulting & market research, technology evaluations and marketing communications services to help clients in the life sciences and health care sectors transform science into commercial success. We believe that InventionEvaluator's comprehensive and cost-effective reports, which assess the marketability of new technologies, should prove valuable to many of our clients."

 

For further information please contact:

 

Tekcapital Plc

+1 305 200 3450 Ext 305

Clifford M. Gross, Ph.D., Executive Chairman

cgross@tekcapital.com

 

 

Health Connexions™

+1 416-402-8274

Dawn Van Dam, President & CEO

dawn.vandam@healthconnexions1.com

 

 

Northland Capital Partners Limited (NOMAD & Broker)

+44 (0) 20 7382 1100

William Vandyk (Corporate Finance)

wvandyk@northlandcp.co.uk

John Howes / Alice Lane (Corporate Broking)

 

 

 

Optiva Securities Limited (Co-Broker)

+44 (0) 20 3137 1904

Jeremy King / Vishal Balasingham

jeremy.king@optivasecurities.com

 

 

FTI Consulting, LLP

+44 (0) 20 3727 1000

Chris Lane / Emma Appleton / Roger Newby

tekcapital@fticonsulting.com

 

   

 

About Tekcapital plc - The World's Largest University Network for Open Innovation

 

Tekcapital helps clients profit from new, university-developed intellectual properties. With our proprietary discovery search engine, linked to 3,300+ universities in 160 countries, coupled with expert scientific review, we provide a turn-key service to make it easy for clients to find and acquire the IP they need to create a competitive advantage. Tekcapital plc is listed on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com

 

 

About Health Connexions, Inc. - Transforming Science into Commercial Success

 

Health Connexions™ works to accelerate the evaluation, adoption and commercialization of new technologies in life sciences, health care and consumer products. With an extensive network of over 5 million contacts, clients can profit from these connections and expertise garnered over the last 15 years. We also provide strategic advisory services around raising capital to fund new opportunities, or to support the growth of established organizations, by connecting capital and science to optimize ROI. For more information, please visit www.healthconnexions.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
SALPKKDBOBKDDBD
Date   Source Headline
8th Mar 20217:00 amRNSBelluscura FDA Clearance
5th Feb 20217:00 amRNSSalarius Update
4th Feb 20212:05 pmRNSSecond Price Monitoring Extn
4th Feb 20212:00 pmRNSPrice Monitoring Extension
2nd Feb 20212:47 pmRNSNotification of Major Shareholding
1st Feb 202111:05 amRNSSecond Price Monitoring Extn
1st Feb 202111:00 amRNSPrice Monitoring Extension
1st Feb 20219:05 amRNSSecond Price Monitoring Extn
1st Feb 20219:00 amRNSPrice Monitoring Extension
1st Feb 20217:00 amRNSCommencement of Trading OTCQB Venture Mkt in USA
12th Jan 20212:05 pmRNSSecond Price Monitoring Extn
12th Jan 20212:00 pmRNSPrice Monitoring Extension
6th Jan 20217:00 amRNSLucyd -Crowdfunding and launch Lyte E glasses
21st Dec 202012:35 pmRNSHolding(s) in Company
7th Dec 20202:49 pmRNSNotification of Major Holdings
3rd Dec 20203:46 pmRNSNotification of Major Holdings
3rd Dec 20209:05 amRNSSecond Price Monitoring Extn
3rd Dec 20209:00 amRNSPrice Monitoring Extension
3rd Dec 20207:00 amRNSBelluscura Update
2nd Dec 20209:00 amRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSSalarius launches on Amazon North America
1st Dec 20203:19 pmRNSTotal Voting Rights
18th Nov 20202:05 pmRNSSecond Price Monitoring Extn
18th Nov 20202:00 pmRNSPrice Monitoring Extension
17th Nov 20204:56 pmRNSNotification of Major Holdings
17th Nov 20207:00 amRNSPlacing to Raise £380,000
30th Oct 20206:08 pmRNSTotal Voting Rights
28th Oct 20207:00 amRNSLucyd Patents
5th Oct 20207:00 amRNSPortfolio Company Update: Guident Ltd
1st Oct 202010:18 amRNSExercise of Stock Options and Total Voting Rights
28th Sep 20207:00 amRNSLucyd Ecommerce management appointment
24th Sep 20207:00 amRNSSalarius Mexican Distribution Agreement
21st Sep 20207:00 amRNSGuident Files Additional Patent
16th Sep 20207:00 amRNSSalarius distribution agreement
14th Sep 20207:00 amRNSGuident Update
7th Sep 20207:00 amRNSGuident Update
27th Aug 20201:44 pmRNSGrant of Stock Options
21st Aug 20207:00 amRNSUnaudited Half-Yearly Report
27th Jul 202012:49 pmRNSResults of Annual General Mtg & Directorate Change
27th Jul 20207:00 amRNSNotice of Investor and Analyst Conference Call
22nd Jul 20207:00 amRNSLucyd Update
13th Jul 20207:00 amRNSInvestor and Analyst Conference Call
7th Jul 20201:16 pmRNSNotification of Major Holdings
30th Jun 20204:43 pmRNSNotice of AGM
17th Jun 20202:52 pmRNSNotification of Major Holdings
17th Jun 20207:30 amRNSPortfolio Company Update: Belluscura plc
16th Jun 20207:00 amRNSGuident Update
29th May 20203:18 pmRNSPosting of Annual Report & Total Voting Rights
22nd May 20201:25 pmRNSNotification of Major Shareholdings
22nd May 20207:00 amRNSGuident Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.